Hess Midstream offers high cash income and durable contracted infrastructure with potential gains from its independent multi-basin transition, but reduced Chevron tariffs and higher leverage threaten future cash-flow resilience.
Hamilton combines profitable specialty underwriting, strong capital returns, and differentiated investment capabilities, but catastrophe losses, volatile investment earnings, and a higher historical valuation multiple constrain near-term upside.
Healthcare Realty offers attractive REIT income and improving medical outpatient property cash flows, but elevated leverage and portfolio restructuring limit the certainty of sustained per-share earnings growth.
Howmet Aerospace combines a durable aerospace manufacturing moat with strong engine and gas-turbine demand, supporting long-term earnings compounding, although demanding cash-flow growth expectations limit its margin of safety.
H2O America combines durable regulated water franchises with Texas-driven growth potential, but heavy capital spending, dilution and regulatory recovery delays may prevent operating expansion from translating into attractive per-share returns.
Hercules Capital offers high dividend income and attractive venture lending returns at a reasonable NAV premium, but borrower credit risks, funding costs, and equity dilution could weaken per-share value creation.
Hilton Grand Vacations offers established hospitality brands, recurring fees and historically inexpensive valuation multiples, but weakening contract sales, high leverage and construction-distorted earnings undermine near-term investment appeal.
Hyatt's premium hotel brands and growing asset-light fee platform offer attractive long-term cash-flow potential, but a demanding valuation and substantial leverage limit the margin of safety.
Hershey offers durable confectionery brands, strong cash generation, and earnings-recovery potential at an attractive historical cash-flow valuation, but persistent chocolate-volume declines could weaken its pricing power and margins.
Haleon's trusted consumer healthcare brands and strong cash generation offer attractive long-term value after a sharp repricing, although weak organic sales growth and China's Centrum restrictions could delay recovery.
Houlihan Lokey combines a durable independent advisory franchise, strong profitability, and M&A recovery potential at a reasonable valuation, although cyclical deal activity and compensation costs remain important earnings risks.
Honeywell Aerospace's certified aircraft systems, recurring aftermarket demand, and expanding backlog support long-term earnings recovery, but persistent supplier bottlenecks and elevated post-spin-off leverage constrain near-term returns.